Article
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.
Journal of the National Comprehensive Cancer Network : JNCCN - 1 Jan 2023
Horbinski Craig, Nabors Louis Burt, Portnow Jana, Baehring Joachim, Bhatia Ankush, Bloch Orin, Brem Steven, Butowski Nicholas, Cannon Donald M, Chao Samuel, Chheda Milan G, Fabiano Andrew J, Forsyth Peter, Gigilio Pierre, Hattangadi-Gluth Jona, Holdhoff Matthias, Junck Larry, Kaley Thomas, Merrell Ryan, Mrugala Maciej M, Nagpal Seema, Nedzi Lucien A, Nevel Kathryn, Nghiemphu Phioanh L, Parney Ian, Patel Toral R, Peters Katherine, Puduvalli Vinay K, Rockhill Jason, Rusthoven Chad, Shonka Nicole, Swinnen Lode J, Weiss Stephanie, Wen Patrick Yung, Willmarth Nicole E, Bergman Mary Anne, Darlow Susan
Abstract excerpt
The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of the following adult CNS cancers: glioma (WHO grade 1, WHO grade 2-3 oligodendroglioma [1p19q codeleted, IDH-mutant], WHO grade 2-4 IDH-mutant astrocytoma, WHO grade 4 glioblastoma), intracranial and spinal ependymomas, medulloblastoma, limited and extensive brain metastases, leptomeningeal metastases, non-AIDS-related primary CNS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
